First-line therapeutic strategy for patients with advanced non-small cell lung cancer with Leu858Arg epidermal growth factor receptor mutations: a Bayesian network meta-analysis

• Váldodahkkit: Chongxiang Chen (Dahkki), Chunning Zhang (Dahkki), Huaming Lin (Dahkki), Qianyin Liu (Dahkki), Limian Wu (Dahkki), Chengzhi Zhou (Dahkki), Jiexia Zhang (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: SAGE Publishing, 2022-10-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Aim: The objective of this network meta-analysis was to determine the most useful first-line therapeutic strategy for patients with advanced (IIIB/IV or relapsed) non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) Leu858Arg or EGFR 19del mutations. Methods: PubMed, the W...